On March 3rd, according to Henan Academy of Medical Sciences, the award ceremony for the "21st Century Global Ophthalmic Leaders List" was held at the Annual Meeting of the Asia-Pacific Academy of Ophthalmology (APAO), where 24 ophthalmic leaders from around the world were honored. Among them, Prof. Wang Ningli, the Dean of the Henan Academy of Medical Sciences and Beijing Tongren Hospital Affiliated to Capital Medical University, was listed. He is also the only scientist from mainland China to be selected.
The APAO Annual Meeting is one of the most influential ophthalmic events in Asia. At this congress, nearly ten thousand top ophthalmic experts from around the world gathered to discuss cutting-edge achievements and technologies. The "21st Century Global Ophthalmic Leaders List" is organized by the prestigious international journal "Asia-Pacific Journal of Ophthalmology" (APJO) with the aim of recognizing the most influential ophthalmologists globally in the 21st century. The goal is to select 100 of the most influential global ophthalmic leaders by the end of the 21st century.
The selection attracted active participation from the global ophthalmic community, receiving a total of 163 nominations. The judging panel, consisting of 30 industry experts from 19 countries, evaluated the candidates. The first batch of 24 winners of the "21st Century Global Ophthalmic Leaders List" came from 12 countries, representing outstanding achievements in their respective fields, highlighting the global coverage and influence of ophthalmology. These outstanding ophthalmic experts have driven the advancement and innovation of ophthalmology, making significant contributions to global eye health.
As the only mainland Chinese selected, Wang Ningli is also a Fellow of the International Academy of Ophthalmology and the President-elect of the World Glaucoma Association(WGA). He is a leading expert in the field of ophthalmology in China and has made outstanding contributions to the international academic development of glaucoma. He has also been selected as one of the "Top 100 Most Influential Ophthalmologists in the World" five times.
With over 30 years of experience in clinical, teaching, and research work in ophthalmology, Wang Ningli has mainly focused on basic and clinical research in glaucoma, cataracts, refractive errors, and genetic eye diseases. He led the team to design and develop the world's first panoramic ultrasound biomicroscope for ophthalmic use with independent intellectual property rights, established a Chinese treatment regimen for closed-angle glaucoma, created a new classification of pathogenesis, and proposed "the Ocular-Cranial Pressure Gradient Theory" for the first time internationally. In recent years, he has published 302 academic papers in the field of glaucoma, ranking first globally. He was the first author to receive the second prize of the National Science and Technology Progress Award in 2013 and 2014, as well as five first prizes at the provincial and ministerial levels, and received awards such as the Ho Leung Ho Lee Science and Technology Award and the Guanghua Engineering Science and Technology Award. (Chinese source: Henan Daily Reporter: Li Qian and Li Xiaomin Proofreader: Song Gencheng and Zhou Jinmiao)
